In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. (NYSE:PFE) has agreed to ...
Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its ...
Pfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn patients about possible cancer risks caused by the anti-heartburn medication Zantac. The ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Pfizer has agreed to pay up to $250mn to settle more than 10,000 US lawsuits over cancer risks associated ...
Pharmaceutical giant Pfizer has settled over 10,000 lawsuits accusing the company of concealing cancer risks associated with its antacid medication, Zantac. The lawsuits, filed in courts across the ...
, opens new tab has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people ...
Pfizer has reached a major settlement in a legal battle concerning its recalled heartburn medication, Zantac. According to a Bloomberg report, Pfizer has agreed to settle over 10,000 lawsuits that ...
BioNTech obtient un financement de 145 millions de dollars pour des usines de vaccins en Afrique 29/05 RE BioNTech obtient jusqu'a 145 millions de dollars d'aide de la CEPI pour des usines ...
Pfizer (NYSE:PFE) has reportedly agreed to pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that the company concealed cancer risks associated with its now-discontinued heartburn ...
Pfizer has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation.